Effects of 2-PAM and TMB-4 on neuromuscular transmission.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001001:Anura; D002217:Carbachol / Q000494:pharmacology; D002415:Cats; D002802:Cholinesterases / Q000494:pharmacology; D003650:Decamethonium Compounds / Q000494:pharmacology; D004576:Electromyography; D009119:Muscle Contraction / Q000187:drug effects*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010830:Physostigmine / Q000494:pharmacology; D011220:Pralidoxime Compounds / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D000970:Antineoplastic Agents; D003650:Decamethonium Compounds; D011220:Pralidoxime Compounds; D011725:Pyridines; D013757:Tetraethylammonium Compounds; D002217:Carbachol; D010830:Physostigmine; D002802:Cholinesterases; D014403:Tubocurarine